Literature DB >> 25825042

Genetic and Phenotypic Characteristics of Staphylococcus aureus Isolates from Cystic Fibrosis Patients in Austria.

Lilian Masoud-Landgraf1, Sophia Johler, Alexandra Badura, Gebhard Feierl, Josefa Luxner, Ute Wagner-Eibel, Ernst Eber, Gernot Zarfel, Andrea J Grisold.   

Abstract

BACKGROUND: Cystic fibrosis (CF) is the most common life-limiting inherited disease in Caucasian populations. While pathological changes can be seen in various organs, morbidity and mortality are mainly related to the respiratory tract, with patients suffering from chronic bronchopulmonary infections with characteristic pathogens including Staphylococcus aureus.
OBJECTIVES: To date, there is only very limited data on the genetic and phenotypic characteristics of S. aureus in CF patients. Therefore, in our study, we characterized 58 S. aureus isolates collected from CF patients in Austria by spa typing, DNA microarray profiling, as well as antimicrobial susceptibility testing in order to determine common genomic and antimicrobial resistance features. The tested strain collection exhibited high genomic diversity.
RESULTS: The 58 isolates were assigned to 16 clonal complexes and 48 spa types and differed greatly regarding their virulence and resistance gene profiles. The predominant clonal complexes were MLST CC30 (22%), CC15 (16%), CC45 (14%), and CC5 (12%), complexes that are highly prevalent worldwide among S. aureus strains isolated from humans colonized or infected with S. aureus. DNA microarray profiles showed a wide variety of genes encoding antimicrobial resistance and virulence factors such as various leukocidins, haemolysins, enterotoxins, exfoliative toxins, toxic shock syndrome toxin, as well as genes involved in adhesion and immune evasion.
CONCLUSIONS: While a large number of strains exhibited resistance to one or several antimicrobial agents, methicillin-resistant S. aureus was found at a low prevalence of 3% (n = 2) only. The two methicillin-resistant S. aureus isolates were assigned to CC152/t355 (SCCmecV) and CC5/t001 (SCCmecI). This is the first study to genetically characterize S. aureus isolates in CF patients in Austria.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25825042     DOI: 10.1159/000377707

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  4 in total

1.  Emergence and spread of worldwide Staphylococcus aureus clones among cystic fibrosis patients.

Authors:  Katarzyna Garbacz; Lidia Piechowicz; Magdalena Podkowik; Aneta Mroczkowska; Joanna Empel; Jacek Bania
Journal:  Infect Drug Resist       Date:  2018-02-22       Impact factor: 4.003

Review 2.  Omics Approaches for the Study of Adaptive Immunity to Staphylococcus aureus and the Selection of Vaccine Candidates.

Authors:  Silva Holtfreter; Julia Kolata; Sebastian Stentzel; Stephanie Bauerfeind; Frank Schmidt; Nandakumar Sundaramoorthy; Barbara M Bröker
Journal:  Proteomes       Date:  2016-03-07

3.  Limited evidence of patient-to-patient transmission of Staphylococcus aureus strains between children with cystic fibrosis, Queensland, Australia.

Authors:  Sharon L Biggs; Amy V Jennison; Haakon Bergh; Rikki Graham; Graeme Nimmo; David Whiley
Journal:  PLoS One       Date:  2022-10-07       Impact factor: 3.752

4.  Analysis and Characterization of Staphylococcus aureus Small Colony Variants Isolated From Cystic Fibrosis Patients in Austria.

Authors:  Lilian Masoud-Landgraf; Gernot Zarfel; Tanja Kaschnigg; Simone Friedl; Gebhard Feierl; Ute Wagner-Eibel; Ernst Eber; Andrea J Grisold; Clemens Kittinger
Journal:  Curr Microbiol       Date:  2016-01-28       Impact factor: 2.188

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.